Ernexa Therapeutics近日参与了虚拟投资者活动"What This Means"环节，重点分享了公司近期与美国食品药品监督管理局（FDA）成功举行的新药临床试验前（Pre-IND）会议。该环节旨在深入解读此次会议对公司研发管线的战略意义。
Ernexa Therapeutics近日参与了虚拟投资者活动"What This Means"环节，重点分享了公司近期与美国食品药品监督管理局（FDA）成功举行的新药临床试验前（Pre-IND）会议。该环节旨在深入解读此次会议对公司研发管线的战略意义。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.